衞星石化(002648.SZ)四季度淨利潤預增78.30%到132.74%
格隆匯 1 月 28日丨衞星石化(002648.SZ)公佈,預計2020年度歸屬於上市公司股東的淨利潤152729.53萬元–171820.72萬元,同比增長20%-35%;扣除非經常性損益後的淨利潤143268.77萬元-162359.96萬元,同比增長12.29%-27.25%。
2020年前三季度公司實現歸屬於上市公司股東的淨利潤90201.05萬元,同比下降2.17%。三季度末隨着全球化工行業下游需求快速好轉,主要產品銷售價格上漲。同時,公司各產品生產裝置運行穩定,成本控制進一步優化。公司四季度歸屬於上市公司股東的淨利潤預計同比增長78.30%到132.74%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.